The Expert Panel for Cosmetic Ingredient Safety (Panel) reviewed the safety of Acetyl Hexapeptide-8 Amide (synonymous with Acetyl Hexapeptide-8 (sans “Amide”)) in cosmetic products; this ingredient is reported to function as a skin conditioning agent – miscellaneous in cosmetics. The Panel reviewed data relevant to the safety of this ingredient in cosmetic formulations, and concluded that Acetyl Hexapeptide-8 Amide is safe in cosmetics in the present practices of use at concentrations up to 0.005%. The Panel further concluded that the available data are insufficient to make a determination that Acetyl Hexapeptide-8 Amide is safe under the intended conditions of use in cosmetic formulations at concentrations greater than 0.005%.
JohnsonWBergfeldWFBelsitoDV, et al.Safety assessment of tripeptide-1, hexapeptide-12, their metal salts and fatty acyl derivatives, and palmitoyl tetrapeptide-7 as used in cosmetics. Int J Toxicol. 2018;37(3):90S-102S.
GrosickiMLataczGSzopaACukierAKieć-KononowiczK. The study of cellular cytotoxicity of argireline - an anti-aging peptide. Acta Biochim Pol. 2014;61(1):29-32.
LimSHSunYThiruvallur MadanagopalTRosaVKangL. Enhanced skin permeation of anti-wrinkle peptides via molecular modification. Sci Rep. 2018;8:1596.
8.
Blanes-MiraCClementeJJodasG, et al.A synthetic hexapeptide (Argireline) with antiwrinkle activity. Int J Cosmet Sci. 2002;24(5):303-310.
9.
GutierrezLMCanavesJFerrer-MontielAReigJAMontalMViniegraS. A peptide that mimics the carboxy-terminal domain of SNAP-25 blocks Ca2+-dependent exocytosis in chromaffin cells. FEBS Lett. 1995;372(1):39-43.
10.
RuizMAClaresBMoralesMECazallaSGallardoV. Preparation and stability of cosmetic formulations with an anti-aging peptide. J Cosmet Sci. 2007;58(2):157-171.
11.
U.S. Food and Drug Administration Center for Food Safety & Applied Nutrition (CFSAN). Voluntary Cosmetic Registration Program - Frequency of Use of Cosmetic Ingredients. College Park, MD. Obtained under the Freedom of Information Act from CFSAN; requested as “Frequency of Use Data” January 4, 2021; received January 21, 2021; 2021.
12.
Personal Care Products Council. Concentration of use by FDA product category: acetyl hexapeptide-8 amide. Unpublished data submitted by the Personal Care Products Council on 7-24-2019; 2019.
13.
WangYWangMXiaoXSHuoJZhangWD. The anti-wrinkle efficacy of Argireline. J Cosmet Laser Ther. 2013;15(4):237-241.
14.
AylottRIByrneGAMiddletonJDRobertsME. Normal use levels of respirable cosmetic talc: preliminary study. Int J Cosmet Sci. 1979;1(3):177-186.
15.
RussellRSMerzRDShermanWTSivertsonJN. The determination of respirable particles in talcum powder. Food Cosmet Toxicol. 1979;17(2):117-122.
16.
CIR Science and Support Committee of the Personal Care Products Council (CIR SSC). 11-3-2015. Cosmetic powder exposure. Unpublished data submitted by the Personal Care Products Council.
LunguCConsidineEZahirSPonsatiBArrastiaSHallettM. Pilot study of topical acetyl hexapeptide-8 in the treatment for blepharospasm in patients receiving botulinum toxin therapy. Eur J Neurol. 2013;20(3):515-518.
19.
HoppelMReznicekGKähligHKotischHReschGPValentaC. Topical delivery of acetyl hexapeptide-8 from different emulsions: influence of emulsion composition and internal structure. Eur J Pharm Sci. 2015;68:27-35.
20.
KraelingMEZhouWWangPOgunsolaOA. In vitro skin penetration of acetyl hexapeptide-8 from a cosmetic formulation. Cutan Ocul Toxicol. 2015;34(1):46-52.
21.
RaikouVVarvaresouAPanderiIPapageorgiouE. The efficacy study of the combination of tripeptide-10-citrulline and acetyl hexapeptide-3. A prospective, randomized controlled study. J Cosmet Dermatol. 2017;16(2):271-278.
